文献速递角膜与眼表疾病

兔离体角膜与巩膜对加替沙星通透性的比较研究

[Comparison of the permeability between the rabbit cornea and sclera ex vivo].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2019-01-01

该实验研究采用Franz扩散池和LC-MS/MS法测定加替沙星滴眼液与眼用凝胶在健康雄性新西兰兔离体角膜和巩膜中的累积渗透量(Qn)及表观渗透系数(Papp),发现两种剂型在巩膜的Qn和Papp均明显高于角膜,提示开发巩膜给药途径具有潜在优势。

要点

  • 加替沙星滴眼液在兔离体角膜和巩膜的Qn分别为177.57和517.52 μg/cm²。
  • 加替沙星滴眼液在兔离体角膜和巩膜的Papp分别为4.34和12.51 cm/s。
  • 眼用凝胶在巩膜的Qn和Papp(411.05 μg/cm²、9.21 cm/s)均高于角膜(151.87 μg/cm²、3.66 cm/s)。

核心结论

  • 已验证的LC-MS/MS法可用于测定加替沙星。
  • 加替沙星滴眼液和眼用凝胶在兔离体巩膜的累积渗透量和表观渗透系数均明显高于角膜,提示开发巩膜给药途径具有潜在优势。

研究设计与样本

  • 实验研究,采用Franz扩散池和健康成年新西兰雄性兔的离体角膜、巩膜进行渗透实验。
  • 以加替沙星滴眼液和眼用凝胶为受试药物,用已验证的液相色谱-串联质谱法(LC-MS/MS)在规定时间点测定渗透液中加替沙星浓度,考察累积渗透量(Qn)和表观渗透系数(Papp),并对不同剂型药物的渗透参数采用t检验进行比较。

主要发现

  • 加替沙星的线性范围为5~1 000 ng/ml。
  • 日内和日间精密度分别为1.7%~2.8%和1.0%~2.3%。
  • 加替沙星滴眼液在兔离体角膜和巩膜的Qn分别为177.57和517.52 μg/cm²,Papp分别为4.34和12.51 cm/s。
  • 加替沙星眼用凝胶在兔离体角膜和巩膜的Qn分别为151.87和411.05 μg/cm²,Papp分别为3.66和9.21 cm/s。

关键数值与推荐

  • 加替沙星LC-MS/MS测定线性范围为5~1 000 ng/ml,日内和日间精密度分别为1.7%~2.8%和1.0%~2.3%。
  • 加替沙星滴眼液兔离体角膜Qn 177.57 μg/cm²、Papp 4.34 cm/s,巩膜Qn 517.52 μg/cm²、Papp 12.51 cm/s。
  • 加替沙星眼用凝胶兔离体角膜Qn 151.87 μg/cm²、Papp 3.66 cm/s,巩膜Qn 411.05 μg/cm²、Papp 9.21 cm/s。

局限性

  • 研究为兔离体角膜和巩膜的实验研究,结果外推至人眼活体需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: Comparison of the permeability between the rabbit cornea and sclera ex vivo by determining the concentration of gatifloxacin using LC-MS/MS method, which may provide the basis for a new route of drug administration. Methods: Experimental study. The permeability of the cornea and sclera in healthy male New Zealand rabbits was evaluated by using Franz diffusion pool. We chose both gatifloxacin ophthalmic solution and gel as the test drugs, and calculated the cumulative permeation amounts (Qn), apparent permeability coefficient(P(app)). Results: The linear range of gatifloxacin was 5-1 000 ng/ml. The intra-day and inter-day precision was 1.7% -2.8% and 1.0% - 2.3%. Q(n) and P(app) of gatifloxacin ophthalmic solution in cornea and sclera ex vivo were 177.57, 517.52 μg/cm(2) and 4.34, 12.51 cm/s respectively, whereas that of gatifloxacin ophthalmic gel were 151.87, 411.05 μg/cm(2) and 3.66, 9.21 cm/s. Conclusion: This validated method could be applied to determine the gatifloxacin. The cumulative permeation amounts and apparent permeability coefficient of sclera are significantly higher than that of cornea for both ophthalmic solution and gel, suggesting that the development of a new route of drug administration based on sclera may have potential advantage. (Chin J Ophthalmol, 2019, 55: 928-932). 目的: 探讨加替沙星在兔离体角膜和巩膜的透过性,为开发新的给药途径提供依据。 方法: 实验研究。采用Franz扩散池和健康成年新西兰雄性兔的角膜、巩膜进行渗透实验,以加替沙星滴眼液和眼用凝胶为受试药物,用已验证的液相色谱-串联质谱法(LC-MS/MS)在规定的时间点测定渗透液中加替沙星的浓度,考察累积渗透量(Qn)、表观渗透系数(P(app))等。对不同剂型药物的渗透参数采用t检验进行比较。 结果: 加替沙星的线性范围为5~1 000 ng/ml,日内和日间精密度在1.7%~2.8%和1.0%~2.3%。加替沙星滴眼液在兔离体角膜和巩膜的Qn分别为177.57和517.52 μg/cm(2);P(app)为4.34和12.51 cm/s;而加替沙星眼用凝胶在兔离体角膜和巩膜的Qn分别为151.87和411.05 μg/cm(2);P(app)为3.66和9.21 cm/s。 结论: 无论加替沙星滴眼液还是眼用凝胶兔离体巩膜累积渗透量和表观渗透系数都明显高于角膜,提示开发巩膜给药途径将有潜在优势。(中华眼科杂志,2019,55:928-932).

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhao X, Chen SC, Tong Y, et al. [Comparison of the permeability between the rabbit cornea and sclera ex vivo]. Zhonghua Yan Ke Za Zhi. 2019. PMID: 31874507. doi:10.3760/cma.j.issn.0412-4081.2019.12.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。